Break it Down: EBR lands vital FDA approval

Melbourne-based EBS secures FDA Approval for World-First Leadless Wise CRT System

Posted: 14th April 2025 Melbourne-based organisation EBR Systems proudly announces that the U.S. Food and Drug Administration (FDA) has granted approval for its WiSE® CRT System. This groundbreaking system is the world’s first and only leadless solution for… The post Melbourne-based EBS secures FDA Approval for World-First Leadless Wise CRT System first appeared on BioMelbourne Network.

Break it Down: EBR lands vital FDA approval

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully reveals all on EBR Systems (ASX:EBR), who have won US FDA approval for its WISE CRT system, the world’s first and only wireless solution for pacing the left side of the heart. Watch the video to learn more.   While EBR Systems is a Stockhead advertiser, it did not sponsor this content.The post Break it Down: EBR lands vital FDA…